Which type of urinary incontinence is characterized by a sudden, intense urge to urinate?

Which type of urinary incontinence is characterized by a sudden, intense urge to urinate?

• A. Urge Incontinence
• B. Mixed Incontinence
• C. Overflow Incontinence
• D. Functional Incontinence

Answer: (A)

Sudden, compelling urge to urinate with or without leakage is urge incontinence. This happens because the detrusor muscle contracts involuntarily during bladder filling, creating a strong, abrupt urge that’s hard to defer and may result in leakage. It’s often linked to an overactive bladder. In contrast, overflow incontinence involves continual leakage when the bladder is overfull due to obstruction or weak detrusor, not just sudden urgency. Functional incontinence comes from an external barrier—mobility or cognitive issues prevent reaching the toilet. Mixed incontinence is a combination of urgency symptoms with other types. Management focuses on reducing urgency and leakage through bladder training, scheduled voiding, pelvic floor exercises, reducing bladder irritants, and medications that calm detrusor overactivity (such as antimuscarinics or beta-3 agonists) as appropriate for the individual.

Sudden, compelling urge to urinate with or without leakage is urge incontinence. This happens because the detrusor muscle contracts involuntarily during bladder filling, creating a strong, abrupt urge that’s hard to defer and may result in leakage. It’s often linked to an overactive bladder.

In contrast, overflow incontinence involves continual leakage when the bladder is overfull due to obstruction or weak detrusor, not just sudden urgency. Functional incontinence comes from an external barrier—mobility or cognitive issues prevent reaching the toilet. Mixed incontinence is a combination of urgency symptoms with other types.

Management focuses on reducing urgency and leakage through bladder training, scheduled voiding, pelvic floor exercises, reducing bladder irritants, and medications that calm detrusor overactivity (such as antimuscarinics or beta-3 agonists) as appropriate for the individual.